Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 86.27

+6.0%

Jan 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2565)	4/19/2010 9:51:08 AM
From: Jibacoa	Read Replies (1) of 3722

CTIC has reported lower revenues in the last 4Qs, but has been able to cut its losses. It needs to climb back above $1 in order to keep its NAZ listing.<g> bigcharts.marketwatch.com Today it announced that it met with and received feedback from the EMEA's medical reviewers regarding its proposed filing of a MAA for pixantrone to treat non-Hodgkin's lymphoma. They said the feedback was supportive of filing on the basis of the PIX301 trial and CTIC expects to submit the MAA in September.<g> The ACTAY is $2 and CTIC seems to have support at the $0.50 level.But I think I will keep my 12 month target at just $1 <g> BigCharts doesn't show any data for CTIC before 2008 <g> However IBD's DailyGraphs show a H of $627 in 2003 <G> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next